Strategic Contribution to Egypt’s COVID-19 Respons

Mission Pharma successfully supported Egyptian health authorities during the COVID-19 pandemic by ensuring the supply of the country’s first Enoxaparin biosimilars, playing a pivotal role in maintaining access to essential anticoagulant therapies during a time of global uncertainty.